Allelotype of non-small cell lung cancer

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 533-539

  Neville, E M ^a   Stewart, M P ^a   Swift, A ^a   Liloglou, T ^a   Ross, H ^a   Gosney, J R ^a   Donnelly, R J ^b   Field, J K ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

allelotype; fractional allele loss; loss of heterozygosity; non small cell lung cancer

Indexed keywords

MICROSATELLITE DNA;

ALLELISM; ARTICLE; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 9P; CHROMOSOME SATELLITE; CLINICAL ARTICLE; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029811825     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.3.533     Document Type: Article

References (33)

1. Pisani P, Parkin DM and Ferlay J: Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55: 891-903, 1993.
2. Testa JR, Siegfried JM, Liu Z, Hunt JD, Feder MM, Litwin S, Zhou J, Taguchi T and Keller S: Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosomal alterations amid frequent and widespread genomic upheaval. Genes Chromosom Cancer 11: 178-194, 1994.
3. Sundaresan V, Ganly P, Haselton P, Rudd R, Sinha G, Blechen NM and Rabbitts P: p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989-1997, 1992.
4. Gazdar AF, Bader S, Hung J, Kishimoto Y, Sekido Y, Sugio K, Virmani A, Fleming J, Carbone DP and Minna JD: Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harbor Symp Quant Biol 59: 565-572, 1994.
5. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minnna JD and Gazdar AF: Allele-specific chromosome 3p deletions occur at an early-stage in the pathogenesis of lung carcinoma. JAMA 273: 558-563, 1995.
6. Kishimoto Y, Sugio K, Mitsudomi T, Oyama T, Virmani AK, Mclntire DD and Gazdar AF: Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinoma. J Cancer Res Clin Oncol 121: 291-296, 1995.
7. Thiberville L, Payne P, Vielkinds J, LeRiche J, Horsman D, Nouvel G, Palcic B and Lam S: Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 55: 5133-5139, 1995.
8. Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugand H and Kitagawa T: Allelotype of non-small cell carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52: 2478-2481, 1992.
9. Sato S, Nakamura Y and Tsuchiya E: Difference of allelotype between squamous-cell carcinoma and adenocarcinoma of the lung. Cancer Res 54: 5652-5655, 1994.
10. Ah-See KW, Cooke TG, Pickford IR, Soutar D and Balmain A: An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 1617-1621, 1994.
11. Nawroz H, Vanderriet P, Hruban RH, Koch W, Ruppert JM and Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152-1155, 1994.
12. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, Rowley H, Taylor K, Whittaker J, Howard P, Beirne JC, Gosney JR, Woolgar J, Vaughan ED, Spandidos DA, and Jones AS: Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 72: 1180-1188, 1995.
13. Neville EM, Stewart MP, Myskow M, Donnelly RJ and Field JK: Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. Oncogene 11: 581-585, 1995.
14. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y and White R: Allelotype of colorectal carcinomas. Science 244: 207-211, 1989.
15. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y and Takahashi T: Three distinct regions involved in human lung cancer. Oncogene 7: 445-449, 1992.
16. Siden TS, Golembieski W, Kumlien J, Rohme D and Smith DI: Physical map of small cell lung cancer deletion region on short arm of human chromosome 3 (3p13-22) based on radiation fusion hybrid analysis. Somatic Cell Mol Genet 20: 121-132, 1994.
17. Kok K, van den Berg A, Veldhuis PMJF, van de Veen AY, Franke M, Schoenmakers EFPM, Hulsbeek MMF, van der Hout AH, de Leij L, van de Ven W and Buys CHCM: A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. Cancer Res 54: 4183-4187, 1994.
18. Mead LJ, Gillespie MT, Irving LB and Campbell LJ: Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res 54: 2307-2309, 1994.
19. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994.
20. Washimi O, Nagatake M, Osada H, Ueda R, Koshikawa T, Seki T and Takahashi T: In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res 55: 514-517, 1995.
21. Xiao S, Li D, Corson JM, Vijg J and Fletcher JA: Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res 55: 2968-2971, 1995.
22. Cairns P, Tokino K, Eby Y and Sidransky D: Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54: 1422-1424, 1994.
23. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA and Goodrow TL: Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54: 5050-5053, 1994.
24. Hayashi N, Sugimoto Y, Tsuchiya E, Ogawa M and Nakamura Y: Somatic mutations of the MTS (multiple tumor suppressor) 1/ CDK41 (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinoma. Biochem Biophys Res Commun 202: 1426-1430, 1994.
25. Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Marek RR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwala M, Xiong Y, Beach DH, Yokota J and Harris CC: Mutations in the p16INK4/MTS/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 55: 1448-1451, 1995.
26. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
27. Fong KM, Zimmerman PV and Smith PJ: Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res 55: 28-30, 1995.
28. Hosoe S, Ueno K, Shigedo Y, Tachibana I, Osaki T, Kumagai T, Tanio Y, Kawase I, Nakamura Y and Kishimoto T: A frequent deletion of chromosome-5q21 in advanced small-cell and non-small-cell carcinoma of the lung. Cancer Res 54: 1787-1790, 1994.
29. Wieland I and Bohm M: Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res 54: 1772-1774, 1994.
30. Wieland I, Bohm M, Arden KC, Ammermuller T, Bogatz S, Viars CS and Rajewsky MF: Allelic deletion mapping on chromosome 5 in human carcinomas. Oncogene 12: 97-102, 1996.
31. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW and Wiseman RW: Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 54: 6257-6264, 1994.
32. Fong A, Kida Y, Zimmerman PV, Ikenago M and Smith PJK: Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res 55: 4268-4272, 1995.
33. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME and Law MG: Allelotype of human bladder cancer. Cancer Res 54: 531-538, 1994.